Developing World Cures
Home        Mission        About Us        Management        Contributions        Contact Us

About Us

Neglected diseases of the developing world afflict greater than one billion people and the toll on human life is enormous. For example, Acute Diarrheal Illness kills 2-3 million children per year in the developing world and 1.2 billion individuals are infected with roundworm. Many of the drugs currently available to treat neglected diseases lack efficacy and have poor safety profiles. The mission of Developing World Cures (DWC) is to discover and develop medicines to treat such diseases.We believe that, regardless of country of birth or residence, all should have access to appropriate medications.

DWC’s leadership will use their knowledge of pharmaceutical R&D and industry contacts  to identify compounds and projects for development. In particular, the company will:

·         Seek donated compounds and other intellectual property from pharmaceutical and biotechnology companies.

·         Collaborate extensively with universities to identify research applicable to developing world diseases.

·         Work with other non-profit entities who have identified projects and/or secured intellectual property but who lack the research and development capabilities of DWC.

·         Identify projects employing off-patent medicines which could be used or modified to treat diseases and conditions for which the expired patent was not originally filed.

The company has been established as an IRC 501(c)(3) non-profit Connecticut corporation and a subsidiary of Connecticut United for Research Excellence (CURE), also organized as a 501(c)(3).  CURE will act as an interface to the state of Connecticut and with Connecticut-based pharmaceutical and biotech companies.